Clinical Trials List
2023-09-15 - 2025-10-22
Phase III
Not yet recruiting2
Terminated3
ICD-10E66.09
Other obesity due to excess calories
ICD-10E66.1
Drug-induced obesity
ICD-10E66.8
Other obesity
ICD-10E66.9
Obesity, unspecified
ICD-9278.00
Obesity unspecified
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yu-Min Huang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳宗伯 Division of Family Medicine
- Hua-Shui Hsu Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳泓裕 Division of Family Medicine
- 陳全裕 Division of Family Medicine
- Kuo-Ting Lee Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
242 participants
